| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sana Biotechnology, Inc. | EVP & President, R&D | Restricted Stock Units | 67,083 | $368,957 | $5.50 | 07 Mar 2024 | Direct |
| Sana Biotechnology, Inc. | EVP & President, R&D | Stock Option (Right to Buy) | 301,875 | 07 Mar 2024 | Direct | ||
| Climb Bio, Inc. | Director | Stock Option (Right to Buy) | 40,000 | 04 Jun 2025 | Direct | ||
| Camp4 Therapeutics Corp | Director | Stock Option (Right to Buy) | 17,787 | 17 Mar 2025 | Direct | ||
| Codiak BioSciences, Inc. | President & CEO, Director | Common Stock | 7,655 | 28 Mar 2023 | Direct | ||
| Camp4 Therapeutics Corp | Director | Common Stock | 2,501 | 17 Mar 2025 | Direct | ||
| Ovid Therapeutics Inc. | Director | Stock Option (Right to Buy) | 1,750 | 17 May 2021 | Direct |